United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022

The United States Breast Cancer Screening Market is administered to an increasing incidence of breast cancer issues, which more forth increase awareness to the breast cancer detection. technological advancements have further made imaging technologies with initiatives to create awareness.

United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022.
 
 Long–term Growth Projection:
 
 • Mammography grasp the dominant share in the United States Breast Cancer Screening Market
 • Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022
 • Number of mammography screening population in United States will increase to more than 50 Million by 2022
 
 Market growth can be attributed to factors such as increased incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.
 
 “United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market. The report provides an in-depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered the mammography screening population from 2010 to 2022.
 
 Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. The breast cancer screening market is segmented based on its product types: Mammography, Breast MRI and Breast Ultrasound. Additionally, the report includes an assessment of clinical trials and reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States Breast Cancer Screening Market.
 
 
 The report concludes with the profiles of major manufacturers of Mammography, MRI and Ultrasound such as Hologic, Hitachi Medical Corporation, Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, and GE Healthcare. The major manufacturers are evaluated on various parameters such as business overview, marketed products, and latest development and trends
 
 Key Topics Covered in the Report
 
 • United States Breast Cancer Cases (2010 - 2022)
 • United States Breast Cancer Mammography Screening Population (2010 – 2022)
 • United States Breast Cancer Death (2010 – 2017)
 • Market Overview: United States Breast Cancer Screening (2010 – 2022)
 • Market Share: United States Breast Cancer Screening (2010 – 2022)
 • By Types (Mammography, Breast MRI & Breast Ultrasound): Market Size & Analysis (2010 – 2022)
 • Reimbursement Policies of the United States Breast Cancer Screening
 • Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
 • Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
 • Key Manufacturers Analysis
 
 
 Major Breast Cancer Screening Analyzed Under This Report Are:
 
 • Mammography
 • Breast Magnetic Resonance Imaging(MRI)
 • Breast Ultrasound
 
 Major Companies Covered in This Report:
 
 • Hitachi Medical Corporation
 • Siemen Healthineers
 • Philips Healthcare
 • Toshiba Medical Systems Corporation
 • GE Healthcare
 • Hologic
  

 1. Executive Summary
 
 2. Breast Cancer Facts
 
 3. United States Breast Cancer Cases & Population (2010 – 2022)
 3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
 3.2 Breast Cancer Occurrence (2010–2022)
 3.2.1 Total Breast Cancer Cases
 3.2.1.1 Breast Cancer Invasive Cases
 3.2.1.2 Breast Cancer In Situ Cases
 3.2.1.3 Breast Cancer Men Cases
 3.3 Breast Cancer Death (2010 – 2017)
 3.3.1 Total Breast Cancer Death
 3.3.1.1 Women Breast Cancer Death
 3.3.1.2 Men Breast Cancer Death
 
 4. Market Overview: United States Breast Cancer Screening (2010 – 2022)
 
 5. Market Share: United States Breast Cancer Screening (2010 – 2022)
 
 6. By Types: Market Size & Analysis (2010 – 2022)
 6.1 Mammography Screening Market
 6.2 Breast Magnetic Resonance Imaging (MRI) Screening Market
 6.3 Breast Ultrasound Screening Market
 
 7. Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
 7.1 Market Drivers
 7.2 Market Inhibitors
 
 8. Reimbursement Policies of the United States Breast Cancer Screening
 8.1 Mammography
 8.2 Breast Magnetic Resonance Imaging(MRI)
 8.3 Breast Ultrasound
 
 9. Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
 9.1 Year 2017
 9.2 Year 2016
 9.3 Year 2015
 
 10. Key Manufacturers Analysis
 10.1 Hologic
 10.1.1 Business Overview
 10.1.2 Breast Cancer Screening – Marketed Products
 10.1.2.1 Mammography
 10.1.2.2 Magnetic Resonance Imaging(MRI)
 10.1.3 Breast Cancer Screening – Latest Development & Trends
 10.2 Hitachi Medical Corporation
 10.2.1 Business Overview
 10.2.2 Breast Cancer Screening – Marketed Products
 10.2.2.1 Magnetic Resonance Imaging(MRI)
 10.2.2.2 Ultrasound
 10.2.3 Breast Cancer Screening – Latest Development & Trends
 10.3 Siemens Healthineers
 10.3.1 Business Overview
 10.3.2 Breast Cancer Screening – Marketed Products
 10.3.2.1 Mammography
 10.3.2.2 Magnetic Resonance Imaging (MRI)
 10.3.3 Breast Cancer Screening – Latest Development & Trends
 10.4 Philips Healthcare
 10.4.1 Business Overview
 10.4.2 Breast Cancer Screening – Marketed Products
 10.4.2.1 Mammography
 10.4.2.2 Magnetic Resonance Imaging (MRI)
 10.4.2.3 Ultrasound
 10.4.3 Breast Cancer Screening – Latest Development & Trends
 10.5 Toshiba Medical Systems Corporation
 10.5.1 Business Overview
 10.5.2 Breast Cancer Screening – Marketed Products
 10.5.2.1 Mammography
 10.5.2.2 Magnetic Resonance Imaging (MRI)
 10.5.2.3 Ultrasound
 10.5.3 Breast Cancer Screening – Latest Development & Trends
 10.6 GE Healthcare
 10.6.1 Business Overview
 10.6.2 Breast Cancer Screening – Marketed Products
 10.6.2.1 Mammography
 10.6.2.2 Magnetic Resonance Imaging (MRI)
 10.6.2.3 Ultrasound
 10.6.3 Breast Cancer Screening – Latest Development & Trends

List Of Tables

 Table 5–1: United States – Breast Cancer Screening Market Share(Percent),2010 – 2016
 Table 5–2: United States – Forecast for Breast Cancer Screening Market Share(Percent),2017 – 2022

List Of Figures

 Figure 3–1: United States – Breast Cancer Mammography Screening Population(Thousand),2010 – 2016
 Figure 3–2: United States – Breast Cancer Mammography Screening Population(Thousand),2017 – 2022
 Figure 3–3: United States – Total Breast Cancer Cases(Number),2010 – 2016
 Figure 3–4: United States – Forecast for Total Breast Cancer Cases(Number),2017 – 2022
 Figure 3–5: United States – Breast Cancer Invasive Cases(Number),2010 – 2016
 Figure 3–6: United States – Forecast for Breast Cancer Invasive Cases(Number),2017 – 2022
 Figure 3–7: United States – Breast Cancer In Situ Cases(Number),2010 – 2016
 Figure 3–8: United States – Forecast for Breast Cancer In Situ Cases(Number),2017 – 2022
 Figure 3–9: United States – Breast Cancer Men Cases(Number),2010 – 2016
 Figure 3–10: United States – Forecast for Breast Cancer Men Cases(Number),2017 – 2022
 Figure 3–11: United States – Total Breast Cancer Death(Number),2010 – 2017
 Figure 3–12: United States – Women Breast Cancer Death(Number),2010 – 2017
 Figure 3–13: United States – Men Breast Cancer Death(Number),2010 – 2017
 Figure 4–1: United States – Breast Cancer Screening Market (Million US$),2010 – 2016
 Figure 4–2: United States – Forecast for Breast Cancer Screening Market (Million US$),2017 – 2022
 Figure 6–1: United States – Mammography Screening Market (Million US$),2010 – 2016
 Figure 6–2: United States – Forecast for Mammography Screening Market (Million US$),2017 – 2022
 Figure 6–3: United States – MRI Screening Market (Million US$),2010 – 2016
 Figure 6–4: United States – Forecast for MRI Screening Market (Million US$),2017 – 2022
 Figure 6–5: United States – Breast Ultrasound Screening Market (Million US$),2010 – 2016
 Figure 6–6: United States – Breast Ultrasound Screening Market (Million US$),2017 – 2022
 
 Companies Mentioned
 
 Hologic,
 Hitachi Medical Corporation,
 Siemen Healthineers,
 Philips Healthcare,
 Toshiba Medical Systems Corporation,
 GE Healthcare
  

Fill The Form For Sample Request

There is no Reviews available